By Carl O’Donnell and Greg Roumeliotis (Reuters) – Italian specialty pharmaceutical company Chiesi Farmaceutici SpA is close to an agreement to acquire some of Medicines Co’s cardiovascular assets for several hundred millions of dollars, according to people familiar with the matter. The transaction would allow Chiesi to expand its global footprint, while freeing up capital for Medicines Co to invest in its drug development pipeline. Based in Parsippany, New Jersey, Medicines Co has a market capitalization of $2.5 billion.
Read the rest here:
Chiesi nears cardiovascular assets deal with Medicine Co: sources
